Senju USA, Inc.

Quick facts

Marketed products

• Olopatadine 0.2%

Phase 3 pipeline

• Placebo TDS
• SUN-131 1.5% TDS · Ophthalmology
  SUN-131 1.5% TDS is a topical sulfonamide antibiotic used to treat bacterial conjunctivitis.

Phase 2 pipeline

• Ketotifen 4.0% Patch

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Senju USA, Inc. portfolio CI brief
• Senju USA, Inc. pipeline updates RSS